Process for the treatment of erectile dysfunction and product therefor

US6465465B1 · kind B1 · utility

Assignee

• Arzneimittelwerk Dresden GmbH · DE

Inventors

• Degenhard Marx · Radebeul, DE
• Norbert Höfgen · Radeberg, DE
• Ute Egerland · Radebeul, DE
• Stefan Szelenyi · Arnstorf, DE
• Thomas Kronbach · Radebeul, DE

Key dates

• Filing date: Feb 8, 2001
• Grant date: Oct 15, 2002
• Expiry date: Feb 8, 2021

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P15/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to the use of pyrido[3,2-e]-pyrazinones of formula 1 as inhibitors of phosphodiesterase 5 for the treatment of erectile dysfunction (impotence).